Matthew Lumley
Vorstandsvorsitzender bei Myosana Therapeutics, Inc.
Aktive Positionen von Matthew Lumley
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Medicxi Ventures (Jersey) Ltd.
 Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London. | Private Equity Investor | 01.01.2023 | - |
Myosana Therapeutics, Inc.
 Myosana Therapeutics, Inc. BiotechnologyHealth Technology Myosana Therapeutics, Inc. is a biotech company develops novel platform technology. The company was founded by Stan Froehner, Nick Whitehead and Steve Runnels and is headquartered in Seattle, WA. | Vorstandsvorsitzender | 01.11.2021 | - |
| Direktor/Vorstandsmitglied | 01.11.2021 | - |
Karriereverlauf von Matthew Lumley
Ausbildung von Matthew Lumley
| King's College London | Doctorate Degree |
| Imperial College London | Undergraduate Degree |
Statistik
International
| Vereinigtes Königreich | 4 |
| Vereinigte Staaten | 2 |
Operativ
| Private Equity Investor | 1 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Consumer Services | 3 |
| Finance | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Medicxi Ventures (Jersey) Ltd.
Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London. | Finance |
Myosana Therapeutics, Inc.
Myosana Therapeutics, Inc. BiotechnologyHealth Technology Myosana Therapeutics, Inc. is a biotech company develops novel platform technology. The company was founded by Stan Froehner, Nick Whitehead and Steve Runnels and is headquartered in Seattle, WA. | Health Technology |
- Börse
- Insiders
- Matthew Lumley
- Erfahrung
